These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 192626
1. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma. Kubo Y, Okuda K, Hashimoto M, Nagasaki Y, Ebata H. Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626 [Abstract] [Full Text] [Related]
2. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Craxi A, Pasqua P, Giannuoli G, Di Stefano R, Simonetti RG, Pagliaro L. Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478 [Abstract] [Full Text] [Related]
3. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. Chien MC, Tong MJ, Lo KJ, Lee JK, Milich DR, Vyas GN, Murphy BL. J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990 [Abstract] [Full Text] [Related]
4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
5. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [Abstract] [Full Text] [Related]
6. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M. Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941 [Abstract] [Full Text] [Related]
7. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [Abstract] [Full Text] [Related]
15. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma. Chen DS, Sung JL, Lai MY. Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625 [Abstract] [Full Text] [Related]
16. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma. Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y. J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131 [Abstract] [Full Text] [Related]
17. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma. Coursaget P, Chiron JP, Barres JL, Barin F, Cottey P, Tortey E, Yvonnet B, Diop B, MBoup S, Diop-Mar I. IARC Sci Publ; 1984 Jun; (63):181-98. PubMed ID: 6085625 [Abstract] [Full Text] [Related]
18. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF). Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087 [Abstract] [Full Text] [Related]